These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15652664)

  • 1. DNA vaccination with the Aleutian mink disease virus NS1 gene confers partial protection against disease.
    Castelruiz Y; Blixenkrone-Møller M; Aasted B
    Vaccine; 2005 Jan; 23(10):1225-31. PubMed ID: 15652664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Immunogenicity Analysis of Whole-Gene Mutation DNA Vaccine of Aleutian Mink Virus Isolated Virulent Strain.
    Liu D; Li J; Shi K; Zeng F; Zong Y; Leng X; Lu H; Du R
    Viral Immunol; 2018; 31(1):69-77. PubMed ID: 28829241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus.
    Bloom ME; Race RE; Hadlow WJ; Chesebro B
    J Immunol; 1975 Oct; 115(4):1034-7. PubMed ID: 51871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMDV Vaccine: Challenges and Perspectives.
    Markarian NM; Abrahamyan L
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of inapparent Aleutian disease virus infection in mink.
    An SH; DePauli FJ; Wright P; Ingram DG
    Res Vet Sci; 1978 Mar; 24(2):200-4. PubMed ID: 206934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced severity of lesions in mink infected transplacentally with Aleutian disease virus.
    Porter DD; Larsen AE; Porter HG
    J Immunol; 1977 Sep; 119(3):872-6. PubMed ID: 70474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with plasmid DNA encoding the hemagglutinin and the nucleoprotein confers robust protection against a lethal canine distemper virus challenge.
    Dahl L; Jensen TH; Gottschalck E; Karlskov-Mortensen P; Jensen TD; Nielsen L; Andersen MK; Buckland R; Wild TF; Blixenkrone-Møller M
    Vaccine; 2004 Sep; 22(27-28):3642-8. PubMed ID: 15315843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of disease caused by Aleutian mink disease parvovirus.
    Alexandersen S
    APMIS Suppl; 1990; 14():1-32. PubMed ID: 2159766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early life DNA vaccination with the H gene of Canine distemper virus induces robust protection against distemper.
    Jensen TH; Nielsen L; Aasted B; Blixenkrone-Møller M
    Vaccine; 2009 Aug; 27(38):5178-83. PubMed ID: 19596418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of genotype on the development of glomerular lesions in mink with Aleutian disease virus.
    Johnson MI; Henson JB; Gorham JR
    Am J Pathol; 1975 Nov; 81(2):321-36. PubMed ID: 53016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for antibodies against Aleutian disease virus (ADV) in mink. Elucidation of dubious results by additive counterimmunoelectrophoresis.
    Uttenthal A
    Appl Theor Electrophor; 1992; 3(2):83-4. PubMed ID: 1335756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibody in Aleutian disease of mink: comparison of enzyme-linked immunosorbent assay and counterimmunoelectrophoresis.
    Wright PF; Wilkie BN
    Am J Vet Res; 1982 May; 43(5):865-8. PubMed ID: 6283966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection from disease.
    Aasted B; Alexandersen S; Christensen J
    Vaccine; 1998 Jul; 16(11-12):1158-65. PubMed ID: 9682374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aleutian disease in mink: virology, immunology and pathogenesis.
    Ingram DG; Cho HJ
    J Rheumatol; 1984 Oct; 11(5):576-7. PubMed ID: 6096541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence.
    Costa SM; Paes MV; Barreto DF; Pinhão AT; Barth OM; Queiroz JL; Armôa GR; Freire MS; Alves AM
    Vaccine; 2006 Jan; 24(2):195-205. PubMed ID: 16122850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of inapparent Aleutian disease virus infection in mink.
    An SH; Ingram DG
    Am J Vet Res; 1977 Oct; 38(10):1619-24. PubMed ID: 201189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
    Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
    Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of Aleutian disease from mink with inapparent infections.
    An SH; Ingram DG
    Am J Vet Res; 1978 Feb; 39(2):309-13. PubMed ID: 204235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
    Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
    Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.